Refractory Multiple Myeloma Pipeline Analysis of 80+ therapies: Key Pharma Players Set to Develop Novel Therapies
05 sept. 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Refractory Multiple Myeloma Pipeline Analysis of 80+ therapies: Key Pharma Players Set to Develop Novel Therapies The increasing incidence, rise...